Actual equipoise (boldenon undecanoate) provides for a very slow release. EQ doesn't become active at the receptors until plasma levels reach approximately 1400. When taking the half life and the slow release of the ester into consideration, you see a compounding effect that doesn't provide this active level until week 6 if doses at 600/week. So, because it won't become truely active until about 6 weeks, you now have to consider the amount of time this level is sustained in order to yield significant gains. Typically, EQ should be ran for at least 16 weeks because the gains are slowly achieved. Don't short yourself by shaving the timeframe. If anything, I would say elongate it.

Bold has been paired with other esters, however. Ace or cyp, which provides for faster releases and sooner kicks. Being paired with the propionate ester is news to me. Haven't seen that before.